Blood glucose levels were lowered to near normal levels in the fasting state and after meals.
Read More »Diabetes In Control
Issue 108 Item 11 Simvastatin, Niacin Reduce Metabolic Syndrome Damage
Atherosclerotic progression was slowed; the rate of cardiac events dropped by 40%.
Read More »Issue 110 Item 9 ADA: The Effect of Orlistat on Glycemic Control Is Independent
Blood glucose improvements independent of weight loss.
Read More »Issue 109 Item 15 Cost-effectiveness of Intensive Glycemic Control
Controlling blood pressure, blood glucose and cholesterol reduces costs and improves the quality of life.
Read More »Issue 111 Item 18 Cozaar (Losartan) Lowered Risk Of Total Mortality In Patients
Treatment with losartan resulted in a 24 per cent reduction in the primary composite endpoint of cardiovascular death, stroke and heart attack.
Read More »New CPHPC Therapy Could Help Millions with Type 2 Diabetes
If amyloid deposits in the pancreas causes diabetes, (theory not universally accepted) then this could be an effective therapy
Read More »Issue 109 Item 4 Postprandial Insulin Deficiency Major Factor Of Deteriorating G
Postprandial insulin deficiency is the most powerful explanatory factor of deteriorating glucose control in newly presenting type 2 diabetes.
Read More »Issue 111 Item 7 Stem Cell Research Considered A Source of New Therapies to Trea
Stem cells are a potential source of tissue for treating diabetes.
Read More »Issue 108 Item 10 Mother’s Birthweight Linked to Gestational Diabetes Mellitus R
Women’s own birthweight is associated with the risk for gestational diabetes mellitus.
Read More »Issue 110 Item 8 ADA: Using the Diabetes Educator to Decreasing Physician Worklo
A nurse practitioner and clinical pharmacist-directed diabetes center improved clinical measures and decreased physician workload.
Read More »
Diabetes In Control. A free weekly diabetes newsletter for Medical Professionals. News and information for Medical Professionals.